<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="23298">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01790113</url>
  </required_header>
  <id_info>
    <org_study_id>Arthrex 003</org_study_id>
    <nct_id>NCT01790113</nct_id>
  </id_info>
  <brief_title>Arthrex Eclipse™ Shoulder Prosthesis</brief_title>
  <official_title>A Prospective, Randomized, Multicenter Study Comparing the Safety and Effectiveness of Arthrex's Eclipse™ Shoulder Prothesis to the Univers™ II Shoulder Prosthesis in Patients With a Degenerative Joint Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Arthrex, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Arthrex, Inc.</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A Prospective, Randomized, Multicenter Study comparing the Safety and Effectiveness of
      Arthrex's Eclipse™ Shoulder to the Univers™ II Shoulder Prosthesis in patients with a
      degenerative joint disease.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this study is to demonstrate non-inferiority of the Arthrex Eclipse™ Shoulder
      Prosthesis to the Arthrex Univers™ II Shoulder Prosthesis for the treatment of degenerative
      joint disease in subjects who are candidates for total shoulder replacement. Non-inferiority
      in terms of safety and effectiveness will be measured by a 2 year composite clinical success
      (CCS) that requires functional improvement, radiographic success, absence of reoperations
      and revision, and lack of serious device-related adverse events.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2013</start_date>
  <completion_date type="Anticipated">February 2017</completion_date>
  <primary_completion_date type="Anticipated">August 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Composite Clinical Success</measure>
    <time_frame>2 year</time_frame>
    <safety_issue>No</safety_issue>
    <description>Composite of Clinical Success includes:
constant score change of greater than 10
Adjusted Constant Score greater than or equal to 54
Radiographical Success: Patient meets acceptance criteria for humeral radiolucency, humeral migration/subsidence, glenoid radiolucency, glenoid migration/subsidence, device condition and periprosthetic fracture.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">350</enrollment>
  <condition>Osteoarthritis</condition>
  <arm_group>
    <arm_group_label>Univer™ II</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Univers™ II Total Shoulder Replacement</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Eclipse™</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Eclipse™ Total Shoulder Replacement</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Univers™</intervention_name>
    <description>Control</description>
    <arm_group_label>Univer™ II</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Eclipse™ Total Shoulder Replacement</intervention_name>
    <description>Investigational</description>
    <arm_group_label>Eclipse™</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. The subject is  &gt; 21  years of age

          2. The subject has continued symptoms in target shoulder despite at least 6 months of
             other treatment modalities(e.g.: anti-inflammatory, physical therapy and steroid
             injections)

          3. The subject has a diagnosis in the target shoulder of one or more of the following:
             osteoarthritis, avascular necrosis, post-traumatic arthritis, or rheumatoid
             arthritis.

          4. The subject presents with pain and functional impairment in the index shoulder,
             measured by an Adjusted Constant Score of ≤50.  Note: The Adjusted Constant Score
             will be calculated from the raw Constant Score to establish patient eligibility.

          5. The subject is willing to receive implantation of the Arthrex™ Shoulder Prosthesis or
             Univers™ II Shoulder Prosthesis.

          6. The subject must be physically and mentally willing and able to comply with all study
             procedures (including follow-up visits and radiographic assessments) until the
             conclusion of the study.

          7. The subject has been informed of the nature of the study and provided written consent
             as approved by the sites local Institutional Review Board or Ethic Review Board.

        Exclusion Criteria:

          1. The subject is likely a candidate for hemi-humeral arthroplasty (i.e.: Avascular
             Necrosis of the humeral head without glenoid involvement (Stages 0-3): Rotator Cuff
             Deficient Shoulder: Glenoid Bone deficiency/deformity that precludes glenoid
             replacement (Walch Type B2 or C) or Fractures of the Proximal Humerus, without
             Glenoid involvement.

          2. The subject has immature bone as defined by the absence of cancellous bone
             patterning, a mature, thick cortex, and stress lines within the cancellous bone.

          3. The subject has obvious defects in bone quality, such as cysts or lesions, in the
             humeral head of the target shoulder, as demonstrated by radiographic evaluation.

          4. The subject has a target shoulder a rotator cuff that is not intact and not
             reconstructible.

          5. The subject has Irreducible 3- and 4- part proximal humeral fractures of the target
             shoulder.

          6. The subject has documented history of foreign-body sensitivity.

          7. Subject with positive pregnancy test, or lactating, or intends to become pregnant
             during treatment period

          8. The subject has history of Schizophrenia, Bipolar Disorder and/or Major Depressive
             Disorder as defined by DSM IV.

          9. The subject is skeletally immature demonstrated radiographically by incomplete
             closure of proximal humeral epiphyses.

         10. The subject is at high risk for poor healing or confounding outcomes [(i.e.:
             clinically significant/ being actively  treated for  renal, hepatic, cardiac
             hematologic disease or  poorly controlled diabetes (HbA1c &gt; 10 mg/dl)]

         11. The subject is on immune-stimulating or immunosuppressive agents

         12. The subject has co-morbidity that reduces life expectancy &lt; 36 month.

         13. The subject seeking or receiving workman's compensation for shoulder injury,

         14. The subject is &gt;  350 lbs

         15. The subject engaged in heavy labor (e.g. repetitive lifting in the excess of more
             than 50 lbs.)

         16. The subject has had surgery in the affected extremity in the last 12 months.

         17. The subject has disabilities of other joints that require pain management therapy.

         18. The subject is engaged in active sports participation. (e.g. weight lifting involving
             upper extremities or involved in contact sports)

         19. The subject is taking  medications known to potentially interfere with bone/soft
             tissue healing (e.g. steroids)

         20. The subject is a  prisoners or wards of the state

         21. The subject has a history of alcohol and/or substance abuse as defined by DSM IV
             (Diagnostic and Statistical Manual Diploma in Social Medicine)

         22. The subject has an active or chronic infection, either systemic or local.

         23. The subject has pathologic fractures of the affected shoulder

         24. The subject has acute trauma of the affected shoulder

         25. The subject has osteoporosis defined as a bone density T score of &lt;   -2.5. (A
             screening Questionnaire for osteoporosis, SCORE (Simple Calculated Osteoporosis Risk
             Estimation) and MORES (Male Osteoporosis Risk Estimation Score), will be used to
             screen patients who require a DEXA (dual energy x-ray absorptiometry)bone mineral
             density measurement.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anthony Romeo, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Midwest Orthopaedics at Rush University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Melissa Hirschberg</last_name>
    <phone>239-216-1894</phone>
    <email>melissa.hirschberg@arthrex.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Banner Research/The CORE Institute</name>
      <address>
        <city>Sun City</city>
        <state>Arizona</state>
        <zip>85351</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Bethany Larsen</last_name>
      <phone>623-537-5695</phone>
      <email>bethany.larsen@thecoreinstitute.com</email>
    </contact>
    <investigator>
      <last_name>Arash Araghi, DO</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>John A Brown, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Orthopedics Stanford University School of Medicine</name>
      <address>
        <city>Redwood City</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elizabeth Handley</last_name>
      <phone>650-721-7614</phone>
      <email>ehandley@stanford.edu</email>
    </contact>
    <investigator>
      <last_name>John Costouros, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Shands Hospital /University of Florida</name>
      <address>
        <city>Gainesville</city>
        <state>Florida</state>
        <zip>32611</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Chris Koenig</last_name>
      <phone>352-273-7372</phone>
      <email>koenicj@ortho.ufl.edu</email>
    </contact>
    <contact_backup>
      <last_name>MaryBeth Horodyski, EdD, ATC, LAT, FNATA</last_name>
      <phone>352-273-7074</phone>
      <email>horodmb@ortho.ufl.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Kevin W Farmer, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rush Orthopaedics at Rush University Medical Center</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60607</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mukesh Ahuja</last_name>
      <phone>312-563-2214</phone>
      <email>mahuja@rushortho.com</email>
    </contact>
    <investigator>
      <last_name>Anthony Romeo, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nikhil Verma, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ellis and Badenhausen Orthopedics PSC</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40223</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Erin Gish</last_name>
      <phone>502-587-1236</phone>
      <email>Erin.Gish@Hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Mark Smith, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Medstar Health Research Institute/Medstar Union Hospital</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21237</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Flossine Brown, BS</last_name>
      <phone>410-554-4451</phone>
      <email>Flossine.Brown@medstar.net</email>
    </contact>
    <investigator>
      <last_name>Jason Stein, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Peninsula Orthopaedics Associates, P.A.</name>
      <address>
        <city>Salisbury</city>
        <state>Maryland</state>
        <zip>21804</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Trish Ireland</last_name>
      <phone>410-749-4154</phone>
      <phone_ext>189</phone_ext>
      <email>tireland@peninsulaortho.com</email>
    </contact>
    <investigator>
      <last_name>Thomas A Brandon, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Essentia Health Duluth</name>
      <address>
        <city>Duluth</city>
        <state>Minnesota</state>
        <zip>55805</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robert J Shultz, RN</last_name>
      <phone>218-786-4126</phone>
      <email>rshultz@eirh.org</email>
    </contact>
    <contact_backup>
      <last_name>Erica Chopskie</last_name>
      <email>Erica.Chopskie@eirh.org</email>
    </contact_backup>
    <investigator>
      <last_name>Jeffery Klassen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Excelsior Orthopedics Foundation of WNY</name>
      <address>
        <city>Amherst</city>
        <state>New York</state>
        <zip>14226</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jamie Radtke</last_name>
      <phone>716-250-6494</phone>
      <email>JRadtke@excelsiorortho.com</email>
    </contact>
    <contact_backup>
      <last_name>Annie Cumbo</last_name>
      <phone>716-250-6494</phone>
      <email>ACumbo@excelsiorortho.com</email>
    </contact_backup>
    <investigator>
      <last_name>Paul Patterson, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>SUNY Upstate Medical Universtiy</name>
      <address>
        <city>East Syracuse</city>
        <state>New York</state>
        <zip>13057</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tina Craig</last_name>
      <phone>315-464-8618</phone>
      <email>CraigT@upstate.edu</email>
    </contact>
    <investigator>
      <last_name>Kevin Setter, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ahuja Medical Center University Hospital</name>
      <address>
        <city>Beachwood</city>
        <state>Ohio</state>
        <zip>44122</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Yousef Shishani</last_name>
      <phone>954-756-1011</phone>
    </contact>
    <investigator>
      <last_name>Rueben Gobezie, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>OhioHealth Research Institute at Grant Medical Center</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43215</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lauren Allison, RN</last_name>
      <phone>614-566-8394</phone>
      <email>lalliso3@ohiohealth.com</email>
    </contact>
    <contact_backup>
      <last_name>Jennifer Mull</last_name>
      <phone>614-566-8195</phone>
      <email>jmull2@ohiohealth.com</email>
    </contact_backup>
    <investigator>
      <last_name>Nathan Long, D.O.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Blair Orthopedic Associate, Inc</name>
      <address>
        <city>Altoona</city>
        <state>Pennsylvania</state>
        <zip>16602</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vicki Lassak</last_name>
      <phone>814-204-1191</phone>
      <email>vlassak@blairortho.com</email>
    </contact>
    <investigator>
      <last_name>Joshua Port, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Providence Orthopaedics Group, LLC_Moore Orthopaedics</name>
      <address>
        <city>Lexington</city>
        <state>South Carolina</state>
        <zip>29072</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jay Patel, PhD</last_name>
      <phone>803-227-8582</phone>
      <email>jay.patel@moorecenter.com</email>
    </contact>
    <contact_backup>
      <last_name>Greg Mangione, PA</last_name>
      <email>greg.mangione@mooreclinic.com</email>
    </contact_backup>
    <investigator>
      <last_name>Earl McFadden, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Midwest Orthopedic Speacility Hospital _Wheaton Franciscan Helathcare-Frankin Inc.</name>
      <address>
        <city>Franklin</city>
        <state>Wisconsin</state>
        <zip>53132</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <lastchanged_date>March 13, 2014</lastchanged_date>
  <firstreceived_date>February 11, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Osteoarthritis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Verapamil</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
